127
Participants
Start Date
October 6, 2016
Primary Completion Date
February 13, 2024
Study Completion Date
February 13, 2024
H3B-8800 (RVT-2001)
H3B-8800 (RVT-2001) orally at specified doses and schedules.
Virginia Cancer Specialist, Fairfax
Hospital General Universitario Gregorio Marañon, Madrid
Clinica Universidad de Navarra, Pamplona
Mayo Clinic Jacksonville, Jacksonville
University of Miami, Miami
Karmanos Cancer Institute, Detroit
Mayo Clinic, Rochester
MD Anderson Cancer Center, Houston
Texas Oncology, Austin
Rocky Mountain Cancer Center, Aurora
Arizona Oncology Associates, Tucson
City of Hope, Duarte
Institut Gustave Roussy, Villejuif
City of Hope, Irvine
Oncology Associates of Oregon, Eugene
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dana Farber Cancer Institute, Boston
Algemeen Ziekenhuis Klina, Brasschaat
AZ Sint-Jan Brugge Oostende AV, Bruges
Universiteit Gent, Ghent
University Hospitals Leuven, Leuven
CHU Amiens-Picardie, Amiens
Centre Hospitalier Universitaire d'Angers (CHU d'Angers), Angers
Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux
Centre Hospitalier - Le Mans, Le Mans
Hôpital Claude Huriez, Lille
Centre Hospitalier Lyon Sud, Pierre-Bénite
Azienda Ospedaliera Universitaria di Bologna - Policlinico S. Orsola Malpighi, Bologna
Fondazione IRCCS Cà Granda Ospedale Policlinico Maggiore, Milan
Fondazione IRCCS Policlinico San Matteo, Pavia
IRCCS Istituto Clinico Humanitas Cancer Center, Rozzano
National Cancer Center, Gyeonggi-do
Daegu Catholic University Medical Center, Daegu
Gachon University Gil Medical Center, Incheon
Asan Medical Center, Seoul
Hanyang University Seoul Hospital, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
The Catholic University of Korea Seoul St. Mary's Hospital, Seoul
Hospital Universitario Valle de Hebrón, Barcelona
Hospital Universitario Fundación Jiménez Díaz, Madrid
Complejo Asistencial Universitario de Salamanca, Salamanca
Hospital Universitario y Politécnico La Fe de Valencia, Valencia
Changhua Christian Hospital, Changhua
Chang-Gung Memorial Hospital, Chiayi, Chiayi City
China Medical University Hospital, Taichung
National Cheng Kung University Hospital, Tainan City
National Taiwan University Hospital, Taipei
Lead Sponsor
Hemavant Sciences GmbH
INDUSTRY